Skip to content

Clinical study for e4bp4-related protein signaling pathway in iodine resistance screening and prognosis evaluation of thyroid cancer

Clinical study for e4bp4-related protein signaling pathway in iodine resistance screening and prognosis evaluation of thyroid cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026750
Enrollment
Unknown
Registered
2019-10-20
Start date
2019-11-30
Completion date
Unknown
Last updated
2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cancer

Interventions

Gold Standard:Diagnosis of imaging.
Index test:E4BP4/SOSTDC1/NIS

Sponsors

Shanghai Jiaotong University, School of Medicine, RenJi Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: According to the definition of iodine refractory in the guidelines for the management of adult thyroid nodules and differentiated thyroid cancer formulated by the American Thyroid Association in 2015, all patients were confirmed to be differentiated thyroid cancer by pathology after total thyroidectomy. According to the diagnostic criteria for distant metastasis, it was suggested that distant metastasis had occurred and had been treated with 131I. Group by: 1. 131I resistance group: after 131I treatment, it was invalid and diagnosed as rai-r DTC by imaging. 2. non 131I resistance group: effective metastatic DTC patients after 131I treatment.

Exclusion criteria

Exclusion criteria: 1. patients with primary thyroid tumor or other tumors in the distant metastasis site; 2. Patients with undifferentiated thyroid cancer; 3. patients who do not have enough tumor tissue for immunohistochemistry.

Design outcomes

Primary

MeasureTime frame
E4BP4;NIS;SOSTDC1;

Countries

China

Contacts

Public ContactChen Jun

Shanghai Jiaotong University, School of Medicine, RenJi Hospital

18601671882@163.com+86 18601671882

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026